Achim Jungbluth

Characterization of tumor necrosis factor-deficient mice

Michael W. Marino, Ashley R. Dunn, Dianne Grail et al. · Proceedings of the National Academy of Sciences · 1997 · 791 citations · Full text

Inhibition of interferon γ induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor

Jennifer Hodge-Dufour, Michael W. Marino, Maureen R. Horton et al. · Proceedings of the National Academy of Sciences · 1998 · 144 citations · Full text

Immune Regulation, Immunology, Immunologic Mechanism +17

Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment

Henry W. Murray, Achim Jungbluth, Erika Ritter et al. · Infection and Immunity · 2000 · 111 citations · Full text

Antiparasitic Agent, Immunology, Immune Regulation +18

Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.

Sydney Welt, Gerd Ritter, Clarence Williams et al. · PubMed · 2003 · 42 citations

OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer

Jonathan Tammela, Akiko Uenaka, Toshiro Ono et al. · International Journal of Oncology · 2006 · 41 citations · Full text

Tumor Biology, Eoc Cell Lines, Cancer Immunosurveillance +15